ABO Blood Group Antigens on Plasma vWF and Red Blood Cells (RBC) of the Recipients after ABO-Matched and Mismatched BMT
| Case . | Recipient . | Blood Group . | Time after BMT (months) . | vWF Conc.(U/dL) . | Blood Group after BMT . | Anti-blood Group Antibody Production . | |||
|---|---|---|---|---|---|---|---|---|---|
| Sex (age) . | Diagnosis . | Recipient . | Donor . | vWF . | RBC . | ||||
| ABO-Mismatched BMT | |||||||||
| Major | |||||||||
| M.H. | M (39) | CML | B | AB | 11 | 171 | B | AB | none |
| S.Y. | F (9) | ALL | O | A | 7 | 169 | O | A | anti-B |
| K.K. | M (32) | AML | O | B | 5 | 192 | O | B | n.d. |
| Minor | |||||||||
| K.Y. | M (17) | SAA | A | O | 9 | 144 | A | O | anti-B |
| T.T. | M (13) | WAS | B | O | 45 | 163 | B | O | anti-A |
| M.O. | F (24) | MDS | B | O | 10 | 92 | B | O | anti-A |
| M.N. | M (36) | ALL | AB | O | 5 | 278 | AB | O | none |
| Major + Minor | |||||||||
| K.F. | F (12) | PRCA | A | B | 38 | 234 | A | B | none |
| ABO-Matched BMT | |||||||||
| Y.S. | M (44) | MDS | A | A | 18 | 189 | A | A | anti-B |
| T.H. | M (37) | ALL | B | B | 35 | 339 | B | B | anti-A |
| M.I. | F (24) | AML | AB | AB | 6 | 272 | AB | AB | none |
| Case . | Recipient . | Blood Group . | Time after BMT (months) . | vWF Conc.(U/dL) . | Blood Group after BMT . | Anti-blood Group Antibody Production . | |||
|---|---|---|---|---|---|---|---|---|---|
| Sex (age) . | Diagnosis . | Recipient . | Donor . | vWF . | RBC . | ||||
| ABO-Mismatched BMT | |||||||||
| Major | |||||||||
| M.H. | M (39) | CML | B | AB | 11 | 171 | B | AB | none |
| S.Y. | F (9) | ALL | O | A | 7 | 169 | O | A | anti-B |
| K.K. | M (32) | AML | O | B | 5 | 192 | O | B | n.d. |
| Minor | |||||||||
| K.Y. | M (17) | SAA | A | O | 9 | 144 | A | O | anti-B |
| T.T. | M (13) | WAS | B | O | 45 | 163 | B | O | anti-A |
| M.O. | F (24) | MDS | B | O | 10 | 92 | B | O | anti-A |
| M.N. | M (36) | ALL | AB | O | 5 | 278 | AB | O | none |
| Major + Minor | |||||||||
| K.F. | F (12) | PRCA | A | B | 38 | 234 | A | B | none |
| ABO-Matched BMT | |||||||||
| Y.S. | M (44) | MDS | A | A | 18 | 189 | A | A | anti-B |
| T.H. | M (37) | ALL | B | B | 35 | 339 | B | B | anti-A |
| M.I. | F (24) | AML | AB | AB | 6 | 272 | AB | AB | none |
CML: chronic myeloid leukemia; ALL: acute lymphocytic leukemia; AML: acute myelogenous leukemia; SAA: severe aplastic anemia; WAS: Wiskott-Aldrich syndrome; MDS: myelodysplastic syndrome; PRCA: pure red cell aplasia; n.d.: not determined.